Annual Conference Planning Committee
CHAIRMAN
Mark Gordon, MS, RAC, vice president, global regulatory strategy and policy, Boston Scientific Corporation
COMMITTEE
Patricia Anderson, RAC, vice president, regulatory services, Canreg Inc.
Melissa Clark, RAC, director, corporate regulatory affairs, Boston Scientific Corporation
Nancy Coulson, worldwide director regulatory affairs, Johnson and Johnson, Cordis
William Cover, PhD, RAC, director, Allergan
Joyce Frey-Vasconcells, PhD, executive director, PharmaNet Development Group
Hal Dayton Hopkins, MBA, RAC, associate director, quality control, Abbott Laboratories
Hutch Humphreys, RAC, senior regulatory affairs associate, Amilyn Pharmaceuticals
Joel Kent, RAC, manager, quality and regulatory affairs, GE Healthcare
Mark Kramer, MS, RAC, executive, regulatory affairs, GE Healthcare
Daniel Mannix, PhD, group director, global regulatory sciences–Europe, Bristol Myers Squibb International
Robert Schiff, MS, PhD, RAC, president and chief executive officer, Schiff and Company Inc.
Raymond Seda, MBA, RAC, manager, regulatory affairs, Latin America, Zimmer Inc.
Kyoichi Tadano, PhD, director, Division of Planning and Coordination, International Affairs Division, Pharmaceuticals and Medical Devices Agency
Susan Tiedy-Stevenson, senior director, regulatory sciences, Hogan & Hartson